We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Microgrippers For Miniature Biopsies to Create New Cancer Diagnostic Screening Paradigm

By HospiMedica International staff writers
Posted on 31 Oct 2024

The standard diagnosis of upper urinary tract cancers typically involves the removal of suspicious tissue using forceps, a procedure that is technically challenging and samples only a single region of the organ. More...

The ureters, which transport urine from the kidneys to the bladder, measure less than five millimeters in diameter and can be up to 30 centimeters long. This size constraint limits the tools that can be used, as well as the quality and quantity of the tissue samples collected. Researchers are now working on developing microgrippers that can be utilized throughout the upper urinary tract, allowing them to capture tiny pieces of tissue from numerous locations and potentially aiding in the early detection of diseases.

A team of researchers at Johns Hopkins University (Baltimore, MD, USA) had earlier created microgrippers for the gastrointestinal tract. In their latest study, they shifted their focus to the upper urinary tract, where the complex anatomy and location pose challenges for obtaining tissue samples. The researchers designed their microgrippers to be incredibly small—less than 750 microns, smaller than the tip of a sharpened pencil. The microgrippers feature a star-like shape with six arms connected by multiple hinges, enabling them to fold into a claw-like form. Once tissue is collected, a magnet can be used to retrieve the microgrippers, which can then be analyzed together to check for cancerous samples. These microgrippers act like a loaded spring and can be produced en masse in sheets coated with food-grade wax that keeps them flat. When exposed to body temperature, the wax softens, releasing the spring’s energy, which allows the microgrippers to fold and exert enough force to pierce and grasp surrounding tissue.

Standard biopsies of the upper urinary tract typically employ a specialized ureteral catheter that guides forceps through the urinary tract to collect tissue. To assess whether the microgrippers could be compatible with this method, the researchers loaded approximately 200 microgrippers into a vial and propelled them through three different commercial catheters using compressed air. They discovered that all catheter types had similar passage rates, with about 80% of the microgrippers successfully navigating through. The team then tested the microgrippers in an ex vivo pig ureter. They deployed the microgrippers into the excised organ and incubated the ureter at body temperature for roughly ten minutes. Afterward, they used a magnet to retrieve the microgrippers, finding that most had successfully collected small clusters of tissue.

As reported in preclinical research published in the journal Advanced Healthcare Materials, the team’s analysis of the collected tissue indicated that the microgrippers could retrieve multiple layers of urothelial cells, demonstrating that this technique can yield diagnostic-quality samples. While each microgripper captures only a small amount of tissue, deploying hundreds into the upper urinary tract could collect an amount comparable to that obtained through traditional biopsy methods. However, this tissue would be gathered from various regions of the organ rather than a single localized area, which could enhance the effectiveness of the microgrippers as a screening tool. Although the current focus is on the upper urinary and gastrointestinal tracts, the microgrippers could potentially be adapted for use in other organs.

“We’re aiming to create a new diagnostic screening paradigm that could find cancerous cells before a visible tumor develops, which could enable earlier cancer detection and jumpstart treatment,” said senior study author David Gracias, Ph.D., a professor at Johns Hopkins University. “We envision using this sampling method to determine the overall health of an entire organ. Clinicians could someday use microgrippers to screen high-risk patients, potentially finding disease before symptoms develop.”


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Antimicrobial Mat
MULTIMAT
New
Measuring Rod
seca 233
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.